{
    "id": 3025,
    "name": "acinar cell carcinoma",
    "source": "DOID",
    "definition": "A carcinoma that has_material_basis_in abnormally proliferating cells, derives_from spindle cells and/or derives_from giant cells. [url:http\\://radiology.rsna.org/content/232/2/554.full]",
    "currentPreferredTerm": null,
    "lastUpdateDateFromDO": "03/24/2020",
    "altIds": [
        
    ],
    "termId": "DOID:3025",
    "evidence": [
        {
            "id": 19066,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical case study, an acinar cell carcinoma patient harboring BRCA2 T2766Nfs*10 and loss of the wild-type allele with disease recurrence and liver metastasis demonstrated complete remission following treatment with Platinol (cisplatin) and TS-1 (tegafur-gimeracil-oteracil potassium) (PMID: 25743105).",
            "molecularProfile": {
                "id": 33959,
                "profileName": "BRCA2 T2766Nfs*10 BRCA2 loss"
            },
            "therapy": {
                "id": 8903,
                "therapyName": "Cisplatin + TS-1",
                "synonyms": null
            },
            "indication": {
                "id": 3025,
                "name": "acinar cell carcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 14156,
                    "pubMedId": 25743105,
                    "title": "Whole exome sequencing reveals recurrent mutations in BRCA2 and FAT genes in acinar cell carcinomas of the pancreas.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/25743105"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "clinicalTrials": [
        {
            "nctId": "NCT02834013",
            "title": "Nivolumab and Ipilimumab in Treating Patients With Rare Tumors",
            "phase": "Phase 0",
            "recruitment": "Recruiting",
            "therapies": [
                {
                    "id": 1627,
                    "therapyName": "Ipilimumab + Nivolumab",
                    "synonyms": null
                }
            ]
        }
    ]
}